# Comparison of Bloodstream Infections With Carbapenem Hetero-resistant vs Carbapenem Resistant Klebsiella Pneumoniae

> **NCT04229498** · — · UNKNOWN · sponsor: **SCARE (Study group for carbapenem resistance)** · enrollment: 300 (estimated)

## Conditions studied

- Bloodstream Infection

## Interventions

- **DRUG:** Monotherapy and combination therapy (all antibiotics that are given by attending pysicians and can be active against Klebsiella pneumoniae will be evaluated)

## Key facts

- **NCT ID:** NCT04229498
- **Lead sponsor:** SCARE (Study group for carbapenem resistance)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04
- **Primary completion:** 2021-04
- **Final completion:** 2021-11
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2020-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04229498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04229498, "Comparison of Bloodstream Infections With Carbapenem Hetero-resistant vs Carbapenem Resistant Klebsiella Pneumoniae". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT04229498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*